MoonLake Immunotherapeutics - Class A — Cash Flow (NASDAQ:MLTX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities —-611.07 K-55.89 M-42.78 M-116.59 M-196.01 M -196.01 M Cash from investing activities —0-32.34 M-25.18 M-205.6 M202.99 M 202.99 M Cash from financing activities —-58.06 K119.69 M479.7 M51.31 M146 M 146 M Free cash flow —-611.07 K-55.91 M-43.06 M-117.11 M-196.04 M -196.04 M

Haberler

Cantor Fitzgerald, Moonlake hissesi için görüşünü korudu

MoonLake, InvestingPro’nun tespitinden sonra %65 yükseldi

Wolfe Research, Moonlake hissesi için hedef fiyatı yükseltti

Rothschild Redburn, düzenleyici netlik sonrası Moonlake hissesini yükseltti

Clear Street, IL-17 verileriyle Moonlake hisse hedefini yükseltti

Clear Street raises Moonlake stock price target on IL-17 data

Cantor Fitzgerald, Moonlake hissesi için tavsiyesini korudu

Cantor Fitzgerald reiterates Moonlake stock rating on axSpA potential

Moonlake hissesi için fiyat hedefi deneme sonuçlarıyla 40 dolara yükseltildi

Moonlake Immunotherapeutics stock price target raised to $40 by H.C. Wainwright on trial results

MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)

MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23